International Expansion
The evaluation phases are well progressed, and the Company looks forward to providing an update to the market when appropriate.
Corporate update
MedAdvisor and EBOS Group Limited entered into a number of commercial agreements to enable MedAdvisor to leverage EBOS’ healthcare portfolio to drive customer acquisition and new revenue opportunities. The Company continues to work closely with all parties to sign formal binding agreements, which will be announced to the market in due course.
Outlook
MedAdvisor has a significant opportunity for expansion within the hospital channel. The Company is now developing a hospital admission and discharge product and process that will leverage MedAdvisor’s capabilities to connect with their primary healthcare providers and help patients increase their adherence.
Despite the lack of updates it sounds like they have been very busy over the last 4 months.
I'm also reading between the lines and seeing that initial scope with EBOS has grown.
I like the statement under International Expansion suggesting product elements are being evaluated.
- Forums
- ASX - By Stock
- Ann: MDR H1 FY2018 Financial Report & Appendix 4D
International Expansion The evaluation phases are well...
Add MDR (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $215.0M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 27.5¢ | $84.31K | 299.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 209547 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 94066 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15939 | 0.335 |
3 | 26030 | 0.330 |
1 | 100000 | 0.325 |
4 | 89161 | 0.320 |
2 | 29526 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 24455 | 1 |
0.380 | 50000 | 1 |
0.385 | 100000 | 1 |
0.390 | 54500 | 1 |
0.395 | 10000 | 1 |
Last trade - 12.52pm 15/11/2024 (20 minute delay) ? |
MDR (ASX) Chart |